Borealis Ventures partners with early-stage entrepreneurs to build market-defining companies in information technology and life sciences.
Business Model:
Revenue: $1.6M
Employees: 51-200
Address: 10 Allen St
City: Hanover
State: NH
Zip: 03755
Country: US
[Borealis Ventures](http://www.borealisventures.com/) partners closely with exceptional entrepreneurs from the earliest stages to build market-defining companies in information technology and life sciences. Borealis is particularly committed to advancing the realm of design and engineering software and has invested for more than a decade in that sector’s most innovative emerging companies in such fields as 3D design, construction management, and data-driven software.
Contact Phone:
+16036431500
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2010 | SpaceClaim | Series D | 17M |
7/2018 | Compass Therapeutics, Inc. | Series A | 0 |
1/2013 | Airstone | Venture Round | 2.5M |
11/2007 | Makeover Solutions | Series A | 7M |
12/2015 | HELIX | Series B | 0 |
3/2007 | Flurry | Series A | 3.5M |
2/2013 | Mosaic Storage Systems | Series A | 0 |
8/2015 | Avitide | Series C | 7.6M |
6/2017 | Newmetrix | Series A | 0 |
7/2020 | Compass Therapeutics, Inc. | Venture Round | 0 |
3/2013 | Avitide | Series A | 1.4M |
10/2005 | SpaceClaim | Series A | 7.5M |
12/2003 | Medical Metrx Solutions | Series B | 3.5M |
5/2014 | HELIX | Series A | 8M |
12/2013 | Sketchfab | Seed Round | 2M |
1/2010 | Adimab | Series D | 8.2M |
9/2005 | Handmark | Series A | 5M |
9/2006 | Handmark | Series B | 5M |
7/2017 | Compass Therapeutics, Inc. | Series A | - |
11/2008 | Adimab | Series C | 4M |
6/2017 | Avitide | Equity | 12M |
5/2014 | Fieldlens | Series A | 0 |
11/2021 | Ankyra | Series B | 45M |
3/2018 | Dandelion Energy | Seed Round | 4.5M |
10/2009 | Vico Software | Series B | 3.6M |
7/2015 | Compass Therapeutics, Inc. | Series A | 16M |
10/2005 | Newforma | Series B | 8M |
3/2008 | enVista | Venture Round | 2M |
5/2007 | enVista | Series A | 5M |
7/2015 | Adored | Seed Round | 2.3M |
10/2005 | GlycoFi Inc. | Series C | 11M |
3/2009 | SpaceClaim | Growth | 7M |
6/2007 | SpaceClaim | Series B | 13.5M |
3/2013 | Avedro | Series D | 0 |
7/2011 | PCD Partners | Venture Round | - |
10/2020 | FidoCure | Series A | 0 |
6/2012 | Vets First Choice | Venture Round | 0 |
6/2009 | enVista | Venture Round | 2.5M |
2/2009 | FetchDog | Series A | 4M |
7/2017 | Dandelion Energy | Seed Round | 2M |
3/2019 | Ovation | Series A | 0 |
12/2020 | Ovation | Series B | 21.5M |
4/2018 | Measurabl | Series A | 7M |
12/2010 | enVista | Series B | 4.1M |
7/2010 | enVista | Debt Financing | 2.5M |
5/2013 | Newforma | Series D | 5.1M |
4/2007 | Newforma | Series C | 8M |
9/2008 | Newforma | Series C | 4M |
5/2018 | Orbit Discovery | Series A | 0 |
7/2021 | Orbit Discovery | Venture Round | 0 |
4/2011 | Wingu | Series A | - |
2/2019 | Teckro | Series C | 0 |
9/2018 | Evox Therapeutics | Series B | 0 |
7/2017 | Smartvid io | Series A | 9.5M |
11/2021 | Ankyra | Series B | 0 |
7/2021 | Orbit Discovery | Venture Round | 0 |
12/2020 | Ovation | Series B | 0 |
10/2020 | FidoCure | Series A | 0 |
7/2020 | Compass Therapeutics, Inc. | Venture Round | 0 |
3/2019 | Ovation | Series A | 0 |
2/2019 | Teckro | Series C | 0 |
9/2018 | Evox Therapeutics | Series B | 0 |
7/2018 | Compass Therapeutics, Inc. | Series A | 0 |
5/2018 | Orbit Discovery | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|